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Abstract: Distinct pathogenic and epidemiological features underlie different Theileria parva
strains resulting in different clinical manifestations of East Coast Fever and Corridor Disease
in susceptible cattle. Unclear delineation of these strains limits the control of these diseases in
endemic areas. Hence, an accurate characterization of strains can improve the treatment and
prevention approaches as well as investigate their origin. Here, we describe a set of single nucleotide
polymorphisms (SNPs) based on 13 near-complete mitogenomes of T. parva strains originating
from East and Southern Africa, including the live vaccine stock strains. We identified 11 SNPs
that are non-preferentially distributed within the coding and non-coding regions, all of which are
synonymous except for two within the cytochrome b gene of buffalo-derived strains. Our analysis
ascertains haplotype-specific mutations that segregate the different vaccine and the buffalo-derived
strains except T. parva-Muguga and Serengeti-transformed strains suggesting a shared lineage
between the latter two vaccine strains. Phylogenetic analyses including the mitogenomes of other
Theileria species: T. annulata, T. taurotragi, and T. lestoquardi, with the latter two sequenced in this
study for the first time, were congruent with nuclear-encoded genes. Importantly, we describe seven
T. parva haplotypes characterized by synonymous SNPs and parsimony-informative characters with
the other three transforming species mitogenomes. We anticipate that tracking T. parva mitochondrial
haplotypes from this study will provide insight into the parasite’s epidemiological dynamics and
underpin current control efforts.
Keywords: Theileria parva; mitogenomes; haplotypes; SNPs; live vaccine
1. Introduction
The protozoan parasite Theileria parva that causes East Coast fever (ECF) and Corridor Disease
(CD) is considered among the most debilitating tick-borne pathogens in cattle over its endemic range
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in East, Central, and Southern Africa [1]. In typical ECF symptoms, the disease severity is mainly
due to the parasites’ ability to transform host lymphocytes [2]. Parasitized lymphocytes proliferate
uncontrollably and disseminate the dividing parasite into multiple host tissues. Their accumulation in
the lungs triggers severe vasculitis, eventually resulting in respiratory failure with death occurring
within three to four weeks of infection [3,4]. With mortalities of up to 100% in susceptible animals,
an estimated one million die per year from an estimated risk population of 28 million cattle mainly
belonging to livestock farmers with economically constrained livelihoods [5].
Thus, control of the parasite is urgent to livelihood improvement efforts among resource-poor
farmers in sub-Saharan Africa, as highlighted by the World Organization for Animal Health (OIE) [6].
Current control methods include strict tick control measures to curtail pathogen transmission.
However, this approach relies heavily on acaricide use, which is unsustainable in the long-run due to
acaricide resistance challenges, and toxicity concerns in food and the environment [7]. Anti-theilerial
chemotherapy is effective but only with early detection of the disease, which is impractical under field
conditions [8,9].
Early observations that cattle acquire long-term immunity when challenged with infected ticks
under a long-acting antibiotic treatment opened avenues for the development of an alternative control
method based on live parasite stocks, which is called the infection and treatment method (ITM) [10,11].
ITM consists of inoculating cattle with cryopreserved T. parva sporozoites combined with simultaneous
treatment with long-acting oxytetracyclines [12]. Early experiments revealed that there were varying
cross-reactivities between geographical strains [13,14]. Due to this limitation, a cocktail of three
immunizing parasite stocks known as the ‘Muguga cocktail’, comprising Serengeti-transformed,
Kiambu 5, and Muguga strains, were combined to achieve broad protection against diverse field
isolates [11]. Several other strains have been immunologically profiled to identify an isolate that
cross-reacts to diverse field strains in ECF endemic areas. Among the identified strains was a Marikebuni
stock isolated from the Kenyan Coast that showed cross-protection against several eastern African
strains and, a Boleni strain from Zimbabwe which, apart from a cross-reactivity against Eastern and
Central African strains, induced mild infections, hence eliminating the need for antibiotic use in ITM
protocol [12].
Historically, ECF is traced to have originated from East Africa and spread southwards,
first being reported in present-day Zimbabwe and eventually into South Africa [1]. Yet, it is notable
that T. parva strains from different geographic regions have varying immunological profiles and
epidemiological features. For example, an ability to induce a carrier state in which recovered animals
remain infective to ticks has been demonstrated in some strains, enabling transmission between cattle
by the vector tick, Rhipicephalus appendiculatus [15–17]. This persistence of vaccine strains raised
initial concerns about spreading foreign parasite genotypes into endemic countries free of the vaccine
parasite stocks, thereby possibly disrupting endemic stability [18].
By contrast, it is also known that some parasite strains, particularly of African buffalo
(Syncerus caffer) origin, induce limited parasitosis and parasitemia, are non-persistent and not efficiently
transmissible between cattle hosts [19]. These strains are known to cause a more acute clinical syndrome
called Corridor Disease in areas where susceptible cattle are exposed to vector ticks infected on buffalo,
which are the primary mammalian carrier hosts [20,21]. Based on its unique clinical presentation,
which differs from classical ECF, these particular strains were initially recognized as Theileria parva
lawrencei in earlier literature; however, this nomenclature was subsequently abolished with increasing
molecular and antigenic data confirming similarities between the two strain populations [22–24].
Further, these data have revealed that cattle transmissible strains are a separately maintained subset
population of those found in buffalo, and to differentiate between the two populations, T. parva strains
are arbitrarily considered to be either of buffalo or cattle-derived for epidemiological reasons [25].
However, the genetic underpinnings of these strain differences are yet to be fully unraveled,
and a precise delineation of the various genotypes is lacking [23]. This is partly because of the
parasite’s biology, which renders it technically unamenable for genomic studies, especially in obtaining
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pure parasite DNA free from host-DNA contamination [26]. An accurate determination of the
origin (buffalo or cattle derived) and geographic spread of strains will help intervention and control
efforts. Additionally, accurate characterization of T. parva strains will help to track their frequency
and distribution in specific populations, and to characterize breakthroughs in areas of live vaccine
field deployments. Further, since T. parva has sexual reproductive phases that are associated with
genetic recombination [27], unraveling the parasite genotypes could enhance the understanding of the
long-term effects of live vaccine components in the field.
Owing to limited or no recombination, uniparental inheritance patterns and a high substitution
rate relative to nuclear genomes, mitochondrial genome studies on related apicomplexan parasites have
provided clues of the geographical origin and variants of parasites [28,29]. However, the utility
of mitochondrial genomes in T. parva in delimiting the strains and their geographical origin
remains unexplored. In this study, we sequenced the mitochondrial genomes of ten T. parva strains,
found within the parasite’s currently known endemic range, as well as some characterized isolates used
as vaccine strains. We also included the mitogenomes of nine other T. parva isolates assembled from
their whole-genome data that are publicly available [30]. Further, this study assessed the divergence
of T. parva from the closely related host-leukocyte transforming species T. annulata, T. taurotragi and
T. lestoquardi with an aim to identify phylogenetically informative mitochondrial characters.
2. Materials and Methods
2.1. Source of Isolates
The parasite material for the different strains consisted of infected frozen ground-up tick
supernatants (GUTS), salivary glands (SG), cattle whole blood, or infected lymphocyte cell lines (Table 1).
The GUTS and SG were collected from archived T. parva-infected R. appendiculatus specimens from early
live vaccination projects. Parasite DNA from GUTS, SG, and cell culture sample sources was extracted
using the NucleoSpin Tissue kit (Macherey-Nagel, Düren, Germany), whereas the NucleoSpin Blood
Mini (Macherey-Nagel) was used to extract DNA from blood samples.
Table 1. Parasite material and origin of isolates used in the current study.
Strain/Isolate Origin Material Used Year Created * Reference
T. parva (Serengeti-transformed) Tanzania GUTS 1981 [31]
T. parva (Boleni) Zimbabwe GUTS 1980 [32]
T. parva (Pugu I) Tanzania Cell culture 1977 n.a.
T. parva lawrencei (Manyara) Tanzania GUTS 1980 [33]
T. parva (Satinsyi) Rwanda GUTS 1981 n.a.
T. parva (Kiambu) Kenya Salivary glands 1980 [34]
T. parva (Marikebuni) Kenya GUTS 1985 [35]
T. parva (Marula) Kenya Blood 2000 [20]
T. parva (Muguga) Kenya Salivary glands 1991 [36]
T. parva (Onderstepoort) South Africa GUTS 1988 [37]
T. taurotragi Tanzania Blood 2003 [38]
T. lestoquardi (Atbara) Sudan Cell culture 2001 [39]
* Indicates the year the material used for this study was created, which may differ from the time when the parasite
was first isolated for some strains. n.a.: not available.
2.2. Next-Generation Sequencing (NGS) T. parva Datasets
We additionally obtained publicly available whole-genome datasets of nine T. parva strains
(DRR002439-46), downloaded in FASTQ from the NCBI (SRA accession number: DRA000613) for
assembly of their mitogenomes sequences (Supplementary Table S2). The details of the parasite strains
are described in a previous study [30]. All NGS datasets comprised 36 nucleotide, single-end sequence
runs performed on the Illumina GAII Analyzer [30].
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2.3. Mitogenome Amplification and Sequencing
Primers were designed based on an alignment of T. parva and T. annulata mitogenomes available
in the GenBank (Accession nos. AB499089 and NW_001091933, respectively). A 5808 bp fragment
was amplified from all isolated DNA extracts (0.5–5 ng) in 25 µL reaction volumes comprising; 0.5 U
of S7 Fusion polymerase (Biozym Scientific, Hessisch Oldendorf, Germany), 5× GC Phusion buffer
(ThermoFisher Scientific GmbH, Darmstadt, Germany), 200 mM of dNTPs mix, and 0.5 µM of each
primer (Supplementary Table S1). The cycling conditions were as follows: 98 ◦C for 30 s, followed by
44 cycles of 98 ◦C for 15 s, 60 ◦C for 25 s, and 72 ◦C for 4 min. The final extension step was maintained
at 72 ◦C for 10 min. Amplification of expected ~5.8 kb fragments was confirmed on 1.5% agarose gels
stained with GRGreen DNA stain (Excellgene, Monthey, Switzerland) under UV trans-illumination.
The amplicons were purified using GeneJET PCR Purification Kit (ThermoFisher Scientific GmbH,
Darmstadt, Germany) before cloning using the Strataclone blunt vector (Agilent Technologies, USA)
under the manufacturer’s instructions. The plasmid was purified using the GenUP™ Plasmid Kit
(biotechrabbit GmbH, Berlin, Germany) and evaluated for targeted inserts based on the EcoRI digestion
(ThermoFisher Scientific GmbH, Darmstadt, Germany). The plasmids were sequenced by Sanger
technology using standard vector primers (LGC Genomics GmbH, Berlin, Germany) and 10 primers
designed in this study to amplify overlapping regions of the mitogenome (Supplementary Table S1).
2.4. Assembly, Mapping, and Annotation
The Sanger generated sequences were assembled in Geneious prime 2020.2.3 (www.geneious.com)
by creating consensus sequences from the approximately 1000 bp overlapping reads aligned to
a reference mitogenome (GenBank Accession: AB499089), which is based on T. parva Muguga
vaccine strain. Similarly, the Illumina NGS reads were mapped with reference to (AB499089) using
the Geneious mapper under medium-low sensitivity with fine-tuning of at least five iterations.
Consensus sequences were generated from contigs based on a threshold of at least 60% of the adjusted
chromatogram quality of contributing bases, while ignoring reads mapped to multiple locations on
the reference. The same GenBank reference was used to map and annotate protein-coding genes (PCGs)
and the known rRNA genes based on nucleotide similarities.
2.5. Phylogenetic Analysis and Identification of Informative Single Nucleotide Polymorphisms (SNPs)
Mitogenome sequence alignments generated using MAFFT [40] as well as concatenated alignments
of cox1 and cob sequences with additional GenBank retrieved sequences of non-transforming
Theileria spp. and Babesia spp. were used to infer maximum-likelihood phylogenies. We selected
best-fit models for nucleotide substitution based on the lowest Bayesian information (BIC) scores
calculated using the jModel Test 2 program and tested nodal support with 100 bootstrap replicates [41].
Phylogenetic trees were generated using PhyML implemented as a plugin within the Geneious software
platform [42].
To avoid the challenges of missing data due to incomplete read coverage of the Illumina assemblies,
we used only the Sanger data to generate the multiple alignments used for the SNPs detection.
We aligned the ten T. parva Sanger-generated mitogenome sequences together with three other
host-transforming species; T. taurotragi, T. lestoquardi and T. annulata (retrieved from GenBank:
NW_001091933). SNPs were identified in Geneious prime with reference to the T. parva Muguga
GenBank AB499089 sequence under default settings, with analysis of the variants on protein translations
based on Mold-Protozoan Mitochondrial genetic code. We determined informative SNPs for the 13
mitogenomes under the parsimony optimality criterion with equal weights for all characters using
PAUP*4.0 software [43].
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2.6. T. parva Mitogenomes Haplotypes Definition and Network Analysis
Using a modified approach from [30], a second set of SNPs with consideration to the ten T. parva
Sanger mitogenomes was extracted from the initial parsimony-informative SNPs. We used DnaSP
v.6.12.03 on the second SNP data set to generate T. parva haplotype data [44] and a median-joining
(M-J) network was constructed using Network V. 10 software (https://www.fluxus-technology.com/)
under default settings to examine relationships among the T. parva mitogenomes [45]. Of the Illumina
assembled mitogenomes, strains that had missing data with respect to the second SNP data set were
excluded from the haplotype analysis.
3. Results
At least ten bidirectional overlapping Sanger reads were obtained for each strain, which were
assembled into mitogenomes sequences ranging in size from 5800 to 5811 bp. The sequences are
archived in NCBI’s GenBank under accession numbers MW172707-MW172717; MW218514. The content
and gene order for all ten T. parva, one T. taurotragi, and one T. lestoquardi mitogenomes were consistent
with previous data, comprising three PCGs, fragmented rRNAs, and no tRNA [46] (Figure 1).
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3.1. Divergence of T. parva from Other Host-Lymphocyte Transforming Theileria sp.
Due to length variations, we considered 5793 positions in the multiple alignment of the
sanger-sequenced T. parva mitogenomes and the three additional host-lymphocyte transforming
Theileria spp. Of the positions considered, there were 42 indels and 1036 SNPs. However, only 662
of the SNPs were parsimony informative across all mitogenome sequences. In terms of percentage
identities of the PCG, cob was the most diverse gene, having 73.2–79.6% identity between T. parva
Muguga strain and the three host-lymphocyte transforming Theileria (Figure 2). Phylogenetic analyses
were congruent both using the whole mitogenomes and the concatenated gene sequences. In all
instances, T. annulata and T. lestoquardi consistently formed an outgroup clade to T. parva and T. taurotragi
(Figure 3; Appendix A, Figure A1).
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Figure 3. Maximum likelihood phylogeny based on (A) near-complete whole mitogenome sequences
(~5.8 kb) and (B) cob sequences (~1.1 kb). The nucleotide substitution models for the tree constructions
as determine by the lowest Bayesian information (BIC) values were TVM + G and GTR + G, respectively.
Bootstrap values are based on 100 replicates. Sequences from this study are in bold.
3.2. T. arva Haplotype Analysis
We used the extracted second set of SNPs, which comprised nine informative SNPs for T. parva
haplotype analysis. As previously noted, we included three Illumina assembled mitogenomes
(Nyakizu from Rwanda, MandaliZ22H10, and Buffalo Z5E5 from Za bia) that had data on all the
determined nine informative SNPs, irrespective of the other missing regions lacking reads coverage.
Life 2020, 10, 334 8 of 16
In total, 13 T. parva strains were considered for the haplotype analysis. The SNPs segregated the T. parva
strains used into seven haplotypes, which we have identified in this study by assigning the TpmtH
prefix numerically beginning with Muguga as a reference sequence (Figure 4). The Muguga strain
isolate was assigned into one haplotype identical to Onderstepoort and Serengeti isolates (TpMtH1).
Similarly, T. parva lawrencei (Manyara) isolated from an African buffalo, and Pugu I, both from Tanzania,
together with a Zambian buffalo isolate (Buffalo Z5E5), formed one haplotype (TpMtH7) that was
characterized by two SNPs within both the cox 1 and cob genes. We presumed Pugu I to have originated
from buffalo T. parva based on analysis of its sporozoite surface (p67) antigen gene, which showed
that it lacked the typical 129 bp deletion that is present in cattle transmissible T. parva [47,48]. The p67
sequence generated (See Appendix A for primer information and cycling conditions) for the Pugu I
isolate is archived under accession no MW183674 in the GenBank.
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Figure 4. A median-joining (MJ) parsimony network for the 13 T. parva haplotype mitogenome
sequences. Node labels TpMtH1-7 represents the unique haplotypes. Lines between nodes indicate
mutation points. Larger and fractionated nodes indicate shared haplotypes with multiple strains,
each marked with a different color key, as shown.
Further, the Marikebuni strain originating from the Kenyan coast, Mandali from Zambia,
and Satinsyi strain from Rwanda formed one haplotype (TpMtH3) characterized by two SNP
transitions relative to T. parva Muguga (Table 2; Figure 4). The Marula and Kiambu-V isolates
formed independent haplotypes (TpMtH4 and 5), but differed with one SNP position (119) between
them (Figure 5). The Boleni isolate (TpMtH6) possessed a transversion mutation within the cox1
gene (SNP 584). This transversion mutation was also notable within the buffalo haplotype (TpMtH7).
Interestingly, all haplotypes deviate from TpMtH1 by a transition (A→G) at SNP position 4060,
which lies in a currently functionally unknown region, but appears to be ancestral in the other
transforming Theileria (Table 2; Figure 5). This transition is the single defining SNP of the Nyakizu
(Rwanda) strain from Muguga, and makes TmMtH2 a central node from which all other haplotypes
deviate. However, there was no apparent differentiation by geographic origin as the M-J network
nodes associated with multiple haplotypes clustered isolates of diverse origin (Figure 4).
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Table 2. SNPs among the seven haplotypes based on the GenBank reference AB499089. The reference
sequence matches haplotype TpMtH1 in the present study.
Haplotype Gene Variant Type Change Codon Change Codon Position AA Change ProteinEffect
Cox1
TpMtH3 Transition C→T GCC→GCT 951
TpMtH4 Transition C→T CTG→TTG 76
TpMtH5 Transition G→A GTG→GTA 36
Transition C→T CTG→TTG 76
TpMtH6 Transversion A→C GTA→GTC 501
TpMtH7 Transversion A→C GTA→GTC 501
Transition C→T TAC→TAT 891
Cox3
TpMtH6 Transition T→C CAA→CAG 555
Cob
TpMtH7 Transition A→G GTT→GCT 848 V→A Substitution
Transition A→G GTA→GCA 851 V→A Substitution
Intergenic SNP position
TpMtH2 Transition A→G 4060
TpMtH3 Transition A→G 4060
TpMtH4 Transition A→G 4060
TpMtH5 Transition T→C 1924
Transition A→G 4060
TpMtH6 Transition A→G 4060
TpMtH7 Transition A→G 4060
Transversion T→A 4382
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3.3. Intraspecific Divergence among T. parva Strains
Relative to the GenBank reference AB499089, an alignment of 10 Sanger-sequenced T. parva
mitogenomes showed variation at 11 sites, all of which were SNPs with no indels observed (Figure 1).
Of the 11 SNPs, only three were found within the intergenic region and involved one transversion within
the haplotype associated with buffalo T. parva. In total, there were three transversion SNPs positions,
two of which were observed within the cob gene of the buffalo-associated haplotype. Among the
genes, cox3 was most conserved with only a single SNPs position within the Boleni mitogenome,
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while the cox1 gene had five mutated positions, all of which were synonymous. The remaining two
SNPs that were found within the cob gene sequences were non-synonymous and resulted in two
contiguous amino acid substitutions in their predicted proteins (Table 2). Both substitutions involved
the valine codon, which was replaced by an alanine amino acid codon. Notably, these substitutions
were only in the haplotype associated with the buffalo T. parva isolates.
4. Discussion
In this study, we describe promising mitogenome-based SNPs that demonstrate precision and
convenience in characterizing T. parva strains. Previously identified nuclear-based markers mainly
based on a panel of mini- and micro-satellites are sometimes biased due to selective amplification of
predominant strain clonotypes during passages through cattle and ticks [27,49]. In addition, since the
design of the initial markers relied on the genome of T. parva Muguga stock, some markers are
possibly biased in detecting diversity within this stock [50]. Although whole-genome SNPs analysis
has been demonstrated to have high discriminatory power in typing vaccine strains, it is yet to find
field applications [50,51]. Additionally, obtaining pure parasite DNA for whole-genome sequencing,
especially for buffalo-derived T. parva is a hurdle due to its biology and may be complicated in the field
where the parasite exists as a mixed diverse population [23,27].
Mitochondrial genomes and their individual genes have been extensively used to study phylogeny
and applied in species identification and delimitation across broad taxonomic levels [52]. The majority
of apicomplexan mitochondrial genomes that have been sequenced to date exhibit an extreme
size reduction, containing at most three protein genes (cox1, cox3, and cob) and fragmented rRNA
genes [53]. The extreme mitogenomes size reduction and a faster coalescence make mtDNA attractive to
study differentiated T. parva population strains. Indeed, our analysis revealed haplotype-defining SNPs
within the T. parva mitogenomes, which are parsimonious with other host-leukocytes transforming
Theileria species. Based on median joining (MJ) parsimony analysis, the T. parva mtDNA sequences
generated were segregated into an unambiguous network, congruent with the existence of multiple
linked lineages. With respect to the T. parva Muguga isolate haplotype, each haplogroup was defined
by synonymous nucleotide changes, except for non-synonymous changes leading to amino acid
substitutions within the cob of the buffalo-associated strains; T. parva lawrencei, T. parva Buffalo Z5E5,
and one field isolate, T. parva Pugu I.
Our analysis identifies T. parva Muguga and Serengeti-transformed as belonging to the same
haplotype characterized by nine defining SNPs positions from the strains used in this study. This is
not surprising as previous studies have demonstrated a similar monoclonal antibody profile and
conservation on their known T. parva antigen coding genes [50,54]. Further, the two strains are
strikingly similar at the whole genome level, with only 420 non-synonymous substitutions in
Serengeti-transformed relative to the Muguga reference genome reported [50]. These substitutions
occur in a paltry 53 genes (out of over 4000 T. parva genes) mainly within polymorphic multicopy gene
families and ATP-binding cassette transporter genes located in subtelomeric ends [50]. With the almost
similar identity of the two strains, our results, in addition to previous studies, question the necessity
of both Muguga and Serengeti-transformed in the trivalent cocktail instead of a divalent cocktail
containing either of the two and Kiambu-V. Interestingly, both Muguga and Serengeti-transformed
T. parva strains also shared the same haplotype with a historical isolate T. parva Onderstepoort,
a laboratory maintained stock isolated in 1937 on the farm Schoonspruit in the Transvaal, South Africa
prior to ECF eradication in this country [1,37,55]. Earlier analyses on three T. parva antigen proteins;
the Polymorphic immunodominant molecule (PIM), sporozoite surface protein (p67), and p104,
have shown that these nuclear-encoded antigen genes are, in fact, identical to those of the Muguga
parasite [50,56]. It is thus conceivable that the ECF-causing strains derive from a common lineage that
can be inferred at the mitochondrial genome.
An important finding of this study is the clustering of buffalo-derived T. parva strains under one
haplotype (TpMtH7) with the same nine SNPs. It is noteworthy that the buffalo strains used in this
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study originate from two different countries (Zambia and Tanzania), while the field isolate (Pugu I) was
isolated during vaccine field trials in Tanzania. And although a Kenyan Buffalo (T. parva LAWR) from
the NGS assembly was not included in the haplotype analysis due to missing data on SNP position (159),
all its other SNPs positions also matched haplotype (TpMtH7) (data not shown). The buffalo has
long been recognized as the natural reservoir of T. parva. The T. parva strains maintained in cattle are
considered a subset population from that maintained in buffalo [23,25]. However, there has not been
a definitive genetic basis to differentiate what constitutes a buffalo-derived T. parva and a cattle-derived
T. parva or whether their designation as a single species is justified [23,56]. The available approach of
their differentiation based on the p67 alleles only provides a preliminary indication of presumptive
exposure of cattle to buffalo T. parva based on alleles-2, 3, and 4, which are considered highly probable
to be of buffalo origin in contrast to allele-1 that is found in cattle transmitted T. parva, but does
not necessarily preclude its presence in buffalo [48,49,57]. Our analysis suggests strain defining
mitochondrial SNPs that are potential markers for buffalo-derived T. parva lineages.
Noticeably, the Boleni strain formed a separate haplotype (TpMt6) that shared a transversion
mutation within the coxI gene with the buffalo haplotype. This strain was isolated from Zimbabwe
from a farm that had experienced a severe theileriosis outbreak in January 1978 [31]. Under the now
obsolete trinomial nomenclature of T. parva, it was named Theileria parva bovis, which was associated
to what was referred to as January disease [58]. The delineation of this strain from our data is
thus a significant find as it agrees with the epidemiological distinctions that have been apparent
from earlier investigations on theilerioses caused by T. parva. Further, our analysis identifies the
Kenyan-Marekebuni, Zambian-Mandali, and Rwandese Satinsyi strains as one haplotype (TpMtH3).
Although the shared haplotypes from widely separated regions may suggest a lack of geographical
differentiation of the haplotypes, our observations could also be because of a limited sample size as
well as through spread by carrier animals.
A high level of interspecies divergence among the transforming Theileria is observed that is
characterized by up to 42 indels with respect to T. parva Muguga. However, a limited polymorphism is
observed amongst the 13 T. parva mitogenomes analyzed, which is also observed in other apicomplexan
species such as Plasmodium falciparum [59]. Of the eleven T. parva SNPs observed, only nine were
informative. We modestly suppose this may be convenient compared to whole-genome-based SNPs in
which up to >120,000 SNPs have been observed in buffalo strains alone [30]. Additionally, we think
our approach to defining SNPs that are foremost parsimonious with other leukocyte transforming
Theileria provides initial indications on the potential of the identified SNPs to be informative for
typing of recently diverged field T. parva strains from common leukocyte transforming ancestor.
Nonetheless, further investigation to test the utility of the SNPs is necessary with a larger field
population across the T. parva endemic range, especially in wildlife-livestock areas where ‘breakthrough’
infections against the trivalent live vaccine are known to occur.
The phylogenetic analysis of both the full-length near-complete mitochondrial genomes and
the concatenated cox1 and cob genes place T. parva and T. taurotragi in one clade, consistent with
previous analyses using nuclear genes such as the 18S RNA gene. The same phylogenetic tree topology
is maintained with the sporozoite surface protein gene and its orthologues in respective leukocyte
host-transforming species [60]. Thus, the mitogenomes data’s observed congruency with nuclear-based
data rules out possibilities of inheritance patterns specific to mitochondria in our analysis.
Our data indicate T. annulata and T. lestoquardi form an outgroup clade among the transforming
parasites, reflecting an allopatric speciation separation from T. parva and T. taurotragi, and conforms
to their currently known demography. Noticeably, T. taurotragi was initially described as a parasite
of the eland (Taurotragus oryx) [61], but is also reported to cause infections in cattle in the known
endemic range (Eastern, Central, and Southern Africa) of T. parva and its tick vector R. appendiculatus,
alongside other tick vectors [38]. As such, co-infections of T. taurotragi and T. parva are, in fact,
frequently common [62]. While the pathogenicity of T. taurotragi in cattle is not clearly understood,
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it has been shown to transform a wide range of host cells in in vitro studies [63], and has been associated
with cases of cerebral theileriosis (BCT) [38,64].
Similarly sympatric, T. annulata and T. lestoquardi, occur within the same currently known
endemic range (N. Africa, S. Asia, and S. Europe) and are transmitted by ticks belonging to
Hyalomma genus. Both are important parasites responsible for heavy economic losses and have
an intertwined epidemiology that poses interpretation challenges in their overlap in affected
countries [65]. Theileria lestoquardi is a parasite of small ungulates and causes malignant ovine
theileriosis, while T. annulata causes bovine tropical theileriosis but also co-infects with the former in
sheep [65–67].
In conclusion, this study catalogs SNPs based on mitogenomes of characterized T. parva strains
and vaccine stocks that can facilitate their tracking in the field. We identify haplotypes defined by
SNPs that are initially parsimonious among transforming Theileria; T. parva, T. annulata, T. taurotragi,
and T. lestoquardi mitogenomes, the latter two reported herein for the first time. We anticipate that
the knowledge of the circulating haplotypes with reference to the live vaccine strains haplotypes
will be insightful in characterizing T. parva epidemiology with important implications for control,
and have a predictive value on the success of live vaccine deployments besides characterization of
breakthrough infections.
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Appendix A
The pugu p67 gene was amplified by PCR in a 25 µL reaction using published
primers [48]. Briefly, the amplification reaction contained; 5× High-Fidelity (HF) Phusion
buffer (ThermoFisher Scientific), 200 µM dNTPs (Biozym Scientific GmbH), 0.5 µM forward
primer (IL 6133: 5′-ACAAACACAATCCCAAGTTC-3′), 0.5 µM reverse primers; IL 7922:
5′-CCTTTACTACGTTGGCG-3′), 0.02 U/µL HF Phusion DNA polymerase, sterile PCR-grade water
(Carl Roth GmbH, Karlsruhe), and 2 µL of template DNA. The amplification cycle was set as follows;
98 ◦C for 30 s, followed by 35 cycles of 98 ◦C for 30 s, an annealing step at 58 ◦C for 40 s, and elongation
at 72 ◦C for 1 min. The final extension step was 10 min at 72 ◦C. The p67 amplicon was purified
using GeneJET PCR Purification Kit (ThermoFisher Scientific), and sequenced using Sanger technology
(LGC Genomics, Berlin). The obtained sequence was translated and evaluated for the presence/absence
of the 43 amino-acid deletions used to categorize cattle and buffalo derived p67 sequences.
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